Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

Recent results from 2 double-blind, placebo-controlled phase III trials (RTOG 0825) and (AVAglio) for first-line treatment of glioblastoma patients with the VEGF antibody bevacizumab, showed similar results, related to overall and progression-free survival. The RTOG 0825 trial indicated, opposed to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Fathpour, Pakzad, Obad, Nina, Espedal, Heidi, Stieber, Daniel, Keunen, Olivier, Sakariassen, Per Ø., Niclou, Simone P., Bjerkvig, Rolf
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2014
Fag:
Letters to the Editor
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3984560/
https://ncbi.nlm.nih.gov/pubmed/24733853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou013
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker